Stocks:
5,472
ETFs:
2,400
Exchanges:
11
Market Cap:
$59.03T
24h Vol:
$10.08B
Dominance:
MSFT:5.13%
Stocklytics Platform
BETA
Instrument logo  DXCM

DexCom Inc

DXCM
72 / 100
High Quality
S&P500
$115.32arrow_drop_down-0.73%-$0.85
Key Stats
Open$116.25
Prev. Close$116.17
EPS1.3
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$44.45B
PE Ratio88.71
LOWHIGH
Day Range114.55
116.42
52 Week Range74.75
139.55
Ratios
P/B Ratio21.67
Revenue$3.62B
Operating M. %20.97%
Earnings$541.50M
Earnings Growth %58.70%
EBITDA Margin %21.64%
ROE %25.78%
EPS1.3
Fundamentals
RPS$9.38
Gross Profit$2.28B
EBITDA$916.70M
Total Debt$2.59B
P/S Ratio12.3x
Enterprise to EBITDA49.27
Profit Margin14.95%
ROA6.41%
Debt/Equity Ratio1.25%
Payout Ratio-
Industry average yield3.04%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell
Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

DXCMarrow_drop_down-1.06%
US Healthcare Sectorarrow_drop_up0.65%
US Marketarrow_drop_up0.51%
DXCM / Market
DXCM lose to the US Market which returned 0.51% over the last twenty four hours.
DXCM / Healthcare Sector
DXCM lose to the US Healthcare sector which returned 0.65% over the last twenty four hours.

DexCom Inc (DXCM) Statistics

DexCom Inc (DXCM) is a renowned medical technology company specializing in the development and commercialization of continuous glucose monitoring (CGM) systems for people with diabetes. With a focus on helping individuals with diabetes manage their condition more effectively, DexCom has become a market leader in this field. The company's CGM systems provide real-time glucose readings, allowing users to monitor and track their blood sugar levels continuously.

Valuation metrics play a crucial role in understanding a company's worth, and DexCom Inc is no exception. By analyzing factors such as the price-to-earnings ratio, price-to-sales ratio, and price-to-book ratio, investors can assess the relative value of DXCM stock. These metrics provide insights into how the market values the company and can guide investment decisions.

add DexCom Inc to watchlist

Keep an eye on DexCom Inc

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
question_mark
How has DexCom Inc (DXCM) stock's performance compared to its sector and the market over the past year?

Over the past year, DexCom Inc (DXCM) has experienced a price change of 5.61%. Compared to the Healthcare sector, which saw a change of 35.64%, DexCom Inc has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 39.15%, it has fallen short of the market average. This comparison highlights DexCom Inc's performance relative to both its sector and the overall market over the last year.

question_mark
What is the PE ratio of DexCom Inc (DXCM) stock?

The PE (Price to Earnings) ratio of DexCom Inc (DXCM) is currently 89.43. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.

question_mark
What is the EPS of DexCom Inc (DXCM) stock?

The Earnings Per Share (EPS) for DexCom Inc (DXCM), calculated on a diluted basis, is $1.3. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.

question_mark
What is the operating margin of DexCom Inc (DXCM) stock?

The operating margin for DexCom Inc (DXCM) is 20.97%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

question_mark
What is the EBITDA of DexCom Inc (DXCM) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of DexCom Inc (DXCM) is $916.7M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

question_mark
How much debt does DexCom Inc (DXCM) have?

DexCom Inc (DXCM) has a total debt of $2.59B. The net debt, which accounts for cash and cash equivalents against the total debt, is $2.03B.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.